AD is characterized by the abnormal deposition of amyloid beta (Aβ) and tau proteins in the brain [2] which, together with other events such as reactive astrogliosis [3] and neurodegeneration, contribute to the onset of cognitive impairment and finally dementia. This evidence concerns the gene MAPT and Alzheimer disease.